Indianapolis, IN, United States of America

Rachel Nicole Richey

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents. Top assignee: Eli Lilly and Company. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rachel Nicole Richey. Retrieved from https://idiyas.com/inventor/rachel-nicole-richey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 1


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rachel Nicole Richey: Innovator in Pharmaceutical Development

Introduction

Rachel Nicole Richey is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative treatments. With a total of 2 patents, her work is recognized for its impact on patient care and therapeutic advancements.

Latest Patents

Richey's latest patents include groundbreaking inventions that address critical health issues. One of her notable patents is focused on "Processes and intermediates for preparing tirzepatide." This invention provides new intermediates and processes useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof. Another significant patent is titled "Treatment of androgen deprivation therapy associated symptoms." This invention offers a method of treating symptoms associated with Androgen Deprivation Therapy by administering an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, to patients in need.

Career Highlights

Rachel Richey is currently employed at Eli Lilly and Company, where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to improving treatment options for patients and advancing medical science.

Collaborations

Throughout her career, Richey has collaborated with esteemed colleagues, including Michael E Kopach and Mark Richard Berglund. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic solutions.

Conclusion

Rachel Nicole Richey exemplifies the spirit of innovation in the pharmaceutical field. Her contributions through her patents and collaborations highlight her dedication to improving healthcare outcomes. Her work continues to inspire future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…